The parents of a toddler who died two months after undergoing heart surgery at North Carolina Children’s Hospital are suing the Chapel Hill institution for failing to disclose issues within its pediatric heart surgery program.
A study published in JACC suggests that, when combined with high-intensity statin therapy, evolocumab can be an effective tool for lowering LDL-cholesterol in patients who have experienced an acute coronary syndrome.
A performance-related financial incentive scheme for general practitioners in the U.K. led to a nearly five-fold increase in the number of heart patients doctors said had been “cured” of atrial fibrillation, according to a recent analysis.
IBM Watson Health is adding startup DiA Imaging Analysis to its AI Marketplace in an effort to offer clinicians access to more objective and accurate ultrasound analysis, the company announced Dec. 1.
Artificial intelligence may be perceived as a threat to some physicians, but, according to research presented at the Radiological Society of North America’s annual meeting in Chicago, it could have some real use for cardiologists.
Beta-blocker use was linked to an increased risk of heart failure hospitalizations in a recent study of patients with “stiff heart” HF—a concerning finding considering the majority of such patients take the drugs as part of their care regimen.
A nine-week mindfulness training course helped hypertensive patients lower their blood pressure and improve healthy habits in a study out of the Mindfulness Center at Brown University’s School of Public Health.
Novoheart, a Vancouver-based stem cell biotech company, is pairing with biopharmaceutical giant AstraZeneca to develop the world’s first human-specific in vitro functional model of heart failure with preserved ejection fraction.
Brushing teeth three or more times a day could dramatically lower a person’s risk for CVDs like heart failure and atrial fibrillation, according to preliminary research out of Ewha Womans University in Seoul, South Korea.
Abbott’s transcatheter tricuspid valve repair system is a safe and effective approach to treating tricuspid regurgitation in heart patients with few other options, according to data published in The Lancet.
Surgical candidates with active cannabis use disorders were nearly twice as likely as their non-user peers to suffer a heart attack after surgery, according to research published in Anesthesiology on Nov. 25.
